BioCentury
ARTICLE | Clinical News

Recombinant platelet factor-4 data

November 20, 1995 8:00 AM UTC

The company presented Phase II data showing equivalent action to protamine, the standard treatment.

In 81 patients, either protamine (50 mg over 10 minutes) or rPF4 (1mg/kg over 2 minutes) was given after the procedure, and both reversed the effects of heparin without side effects. ...